Phones for Undetected Diabetes Mellitus & Hypertension Screening V1.0

  • Research type

    Research Study

  • Full title

    Phones for Undetected Diabetes Mellitus and Hypertension Screening (PUMAS) Study

  • IRAS ID

    333201

  • Contact name

    Tim Chico

  • Contact email

    t.j.chico@sheffield.ac.uk

  • Sponsor organisation

    SHEFFIELD TEACHING HOSPITALS NHS FOUNDATION TRUST

  • Duration of Study in the UK

    0 years, 6 months, 0 days

  • Research summary

    Conditions such as high blood pressure, diabetes, high cholesterol and kidney damage are common in the UK. Detecting these conditions early is helpful, as people can make changes to their lifestyle and take medications to control them. However, currently many people don't know they have these conditions, which leads to preventable ill health, and costs to the NHS. Tests for these conditions involve either a blood test or blood pressure measurement, at the GP surgery, pharmacy or hospital outpatients. Smartphones may potentially offer ways to detect these conditions and could potentially make tests more widely available in the community.

    The goal of the study is to determine whether diabetes, hypertension, high cholesterol and kidney damage could be detected using smartphones. Smartphones can detect a range of different signals, including light, radar, electric signals from the heart.This study is a collaboration between the University of Sheffield and Google involving sites in the UK and USA. The study is funded by Google.

    Research staff will collect information about participants’ health. They will use mobile phones to measure a range of signals, and monitor blood pressure, and tracings from the heart and chest. Participants will have blood tests for diabetes, cholesterol and kidney disease. Information about their blood pressure and blood results will be shared with the participant and their GP.

    All information will be gathered in a single visit, expected to take one hour. The data collected will be handled following appropriate UK and international standards. Analysis of study data that cannot be used to identify participants will occur in the UK and USA. The results of this study will be made public through medical journals, news articles, and other reports.

  • REC name

    Yorkshire & The Humber - South Yorkshire Research Ethics Committee

  • REC reference

    23/YH/0251

  • Date of REC Opinion

    9 Nov 2023

  • REC opinion

    Favourable Opinion